NO20030998L - Arylpiperazinderivater og deres anvendelse som psykotropiske midler - Google Patents

Arylpiperazinderivater og deres anvendelse som psykotropiske midler

Info

Publication number
NO20030998L
NO20030998L NO20030998A NO20030998A NO20030998L NO 20030998 L NO20030998 L NO 20030998L NO 20030998 A NO20030998 A NO 20030998A NO 20030998 A NO20030998 A NO 20030998A NO 20030998 L NO20030998 L NO 20030998L
Authority
NO
Norway
Prior art keywords
psychotropic agents
arylpiperazine derivatives
arylpiperazine
derivatives
psychotropic
Prior art date
Application number
NO20030998A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030998D0 (no
Inventor
Rudolf Gottschlich
Dieter Dorsch
Gerd Bartoszyk
Juergen Harting
Christoph Seyfried
Christoph Van Amsterdam
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20030998L publication Critical patent/NO20030998L/no
Publication of NO20030998D0 publication Critical patent/NO20030998D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20030998A 2000-09-05 2003-03-04 Arylpiperazinderivater og deres anvendelse som psykotropiske midler NO20030998D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10043659A DE10043659A1 (de) 2000-09-05 2000-09-05 Arylpiperazinderivate
PCT/EP2001/009108 WO2002020491A1 (de) 2000-09-05 2001-08-07 Arylpiperazinderivate und deren verwendung als psychopharmaka

Publications (2)

Publication Number Publication Date
NO20030998L true NO20030998L (no) 2003-03-04
NO20030998D0 NO20030998D0 (no) 2003-03-04

Family

ID=7655009

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030998A NO20030998D0 (no) 2000-09-05 2003-03-04 Arylpiperazinderivater og deres anvendelse som psykotropiske midler

Country Status (15)

Country Link
US (1) US20040014972A1 (sk)
EP (1) EP1326842A1 (sk)
KR (1) KR20030024913A (sk)
CN (1) CN1452614A (sk)
AU (1) AU2001291744A1 (sk)
BR (1) BR0113581A (sk)
CA (1) CA2421219A1 (sk)
CZ (1) CZ2003809A3 (sk)
DE (1) DE10043659A1 (sk)
MX (1) MXPA03001826A (sk)
NO (1) NO20030998D0 (sk)
PL (1) PL360289A1 (sk)
SK (1) SK3612003A3 (sk)
WO (1) WO2002020491A1 (sk)
ZA (1) ZA200302636B (sk)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE424825T1 (de) 2001-07-20 2009-03-15 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
WO2004082570A2 (en) * 2003-03-17 2004-09-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with dopamine receptor d2 (drd2)
WO2004113333A1 (ja) * 2003-06-23 2004-12-29 Dainippon Sumitomo Pharma Co., Ltd. 老人性痴呆症治療剤
ES2250000B1 (es) * 2004-09-29 2007-06-01 Medichem, S.A. Procedimiento para la preparacion de ziprasidona.
ES2250001B1 (es) * 2004-09-29 2007-06-01 Medichem, S.A. Proceso para la purificacion de ziprasidona.
KR100660142B1 (ko) * 2005-01-24 2006-12-20 이명섭 건식 모래 생산 방법 및 그 시스템
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
TW200808730A (en) * 2006-06-09 2008-02-16 Wyeth Corp Process for synthesizing piperazine-piperidine compounds
TW200831096A (en) * 2006-11-28 2008-08-01 Wyeth Corp Metabolites of 5-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof
EP2137162B1 (en) 2007-03-15 2018-08-01 Novartis AG Organic compounds and their uses
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
AU5343498A (en) * 1997-01-21 1998-08-07 Yoshitomi Pharmaceutical Industries, Ltd. Thiophene compounds and medicinal use thereof
ES2128266B1 (es) * 1997-07-08 2000-01-16 Vita Invest Sa Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes.
EP0900792B1 (en) * 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists

Also Published As

Publication number Publication date
DE10043659A1 (de) 2002-03-14
SK3612003A3 (en) 2003-07-01
CN1452614A (zh) 2003-10-29
EP1326842A1 (de) 2003-07-16
CA2421219A1 (en) 2003-03-03
BR0113581A (pt) 2003-07-15
WO2002020491A1 (de) 2002-03-14
MXPA03001826A (es) 2003-06-04
ZA200302636B (en) 2004-09-08
CZ2003809A3 (cs) 2003-06-18
AU2001291744A1 (en) 2002-03-22
KR20030024913A (ko) 2003-03-26
US20040014972A1 (en) 2004-01-22
NO20030998D0 (no) 2003-03-04
PL360289A1 (en) 2004-09-06

Similar Documents

Publication Publication Date Title
DK1498413T3 (da) 4-aminopicolinater og deres anvendelse som herbicider
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
DK1282611T3 (da) Substituerede phenylacetatamider og anvendelse deraf som glucokinaseaktivatorer
NO20021253L (no) Kinolylpropylpiperidinderivater og deres anvendelse som antibakterielle midler
NO20020383D0 (no) Mutilinderivater og deres anvendelse som anti-bakterielle midler
NO20031952L (no) 3-aroylinderivater og deres anvendelse som CB2 reseptoragonister
NO20026010D0 (no) Substituerte quinazolinderivater og deres anvendelse som inhibitorer
DK1133477T3 (da) Substituerede benzimidazoler og deres anvendelse som parpinhibitorer
DK1204649T3 (da) Arylmethylcarbonylaminothiazolderivater og deres anvendelse som antitumormidler
NO20033566L (no) Acylerte 6,7,8,9-tetrehydro-5H-benzocykloheptenyl-aminer og deres anvendelse som farmasöytiske midler
NO20024742D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
DK1478629T3 (da) N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler
NO20014702L (no) Diarylderivater og deres anvendelse som medikamenter
NO20025150L (no) 2-acylindolderivater og deres anvendelse som antitumormidler
NO20042635L (no) 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
NO20023146L (no) Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
NO20030998D0 (no) Arylpiperazinderivater og deres anvendelse som psykotropiske midler
NO20030382L (no) Nye indolderivater og deres anvendelse som medikamenter
DK1265892T3 (da) Isothiazolderivater og deres anvendelse som pesticider
NO20030813L (no) Bifenylderivater og deres anvendelse som integrininhibitorer
DK1532141T3 (da) 2-pyrrolidin-2-yl-[1,3,4]-oxadiazol-derivater og anvendelse deraf som antidepressiv
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
DK1492796T3 (da) Substituerede aminoisoxazolinderivater og deres anvendelse som antidepressive midler